| 品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| 阿拉丁 | A124067-1g | 1g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
≥98% |
|
|
| 阿拉丁 | A124067-5g | 5g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
≥98% |
|
|
| 阿拉丁 | A124067-25g | 25g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
≥98% |
|
|
| 阿拉丁 | A1500705-1ml | 1ml | 期货,请咨询 | 32974-92-8 |
2-Acetyl-3-ethylpyrazine 2-Acetyl-3-ethylpyrazine |
Moligand™, 10 mM in DMSO |
|
|
| 罗恩 | R014542-5g | 5g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 罗恩 | R014542-1g | 1g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 罗恩 | R014542-25g | 25g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 麦克林 | A801752-1g | 1g | 订前询问 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
0.98 |
|
|
| 麦克林 | A801752-5g | 5g | 订前询问 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
0.98 |
|
|
| 麦克林 | A801752-25g | 25g | 订前询问 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
0.98 |
|
|
| MARY | MR125653-1g | 1g | 订前咨询 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| MARY | MR125653-5g | 5g | 订前咨询 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 韶远 | SY027477-25g | 25g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
≥95% |
|
|
| 源叶 | B34241-5mg | 5mg | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
HPLC≥99% |
|
|
| 源叶 | S46011-1g | 1g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 源叶 | S46011-5g | 5g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 源叶 | S46011-25g | 25g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 2-Acetyl-3-ethylpyrazine |
98% |
|
|
| 毕得 | BD5160-5g | 5g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 1-(3-Ethylpyrazin-2-yl)ethan... |
98% |
|
|
| 毕得 | BD5160-10g | 10g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 1-(3-Ethylpyrazin-2-yl)ethan... |
98% |
|
|
| 毕得 | BD5160-25g | 25g | 现货 | 32974-92-8 |
2-乙酰基-3-乙基吡嗪 1-(3-Ethylpyrazin-2-yl)ethan... |
98% |
|
|